Genetic testing in the management of hypercholesterolaemia
By Professor Graeme Suthers, Director of Genetics, Sonic Pathology Australia
Hypercholesterolaemia is one of the most common conditions encountered in general practice. Approximately one in 16 Australians has hypercholesterolaemia, and clinicians are very familiar with management recommendations and the challenges of achieving therapeutic goals.
The recent addition of genetic testing for hypercholesterolaemia to the Medicare Benefits Schedule represents a major step forward in the management of this disorder. GPs are the key to effective utilisation of this genetic testing in the Australian community.
The typical patient with hypercholesterolaemia has genetic variants in multiple genes which predispose to the development of hypercholesterolaemia. Each variant makes ...